Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector

Jinwook Shin1, Shang Wang, Wenhai Deng

  • 1Departments of Pediatrics and Immunology, Duke University Medical Center, Durham, NC 27710.

Insights

Mammalian target of rapamycin complex 1 (mTORC1) is essential for invariant natural killer T (iNKT)-cell development and function. Ablating mTORC1 signaling severely impairs iNKT-cell numbers, proliferation, and cytokine production, impacting immune responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Invariant natural killer T (iNKT) cell development and function mechanisms remain largely unknown.
  • Mammalian target of rapamycin (mTOR) is a key regulator of cellular processes, integrating environmental signals.
  • mTOR signaling pathways are crucial for immune cell homeostasis and function.

Purpose of the Study:

  • To investigate the role of mTOR complex 1 (mTORC1) signaling in iNKT-cell development and function.
  • To determine the impact of mTORC1 pathway disruption on iNKT-cell numbers, proliferation, and effector functions.
  • To elucidate the downstream molecular mechanisms, including transcription factor regulation, affected by mTORC1 signaling in iNKT cells.

Main Methods:

  • Conditional deletion of Raptor, a component of mTORC1, in iNKT cell precursors.
  • Assessment of iNKT-cell development, numbers, and distribution in thymus and periphery.
  • In vitro and in vivo functional assays measuring iNKT-cell proliferation and cytokine production upon stimulation.
  • Analysis of liver inflammation in an iNKT cell-mediated hepatitis model.
  • Evaluation of promyelocytic leukemia zinc-finger (PLZF) localization and function in Raptor-deficient iNKT cells.

Main Results:

  • Conditional ablation of Raptor (mTORC1 component) caused severe defects in early iNKT-cell development.
  • Significant reductions in iNKT-cell numbers were observed in both thymus and peripheral tissues.
  • Loss of Raptor impaired iNKT-cell proliferation and cytokine production following stimulation.
  • Raptor deficiency inhibited iNKT cell-mediated liver inflammation.
  • Aberrant intracellular localization and impaired function of the transcription factor PLZF were noted in deficient iNKT cells.

Conclusions:

  • mTORC1 signaling is indispensable for the proper development of iNKT cells.
  • mTORC1 plays a critical role in regulating iNKT-cell proliferation, cytokine production, and effector functions.
  • Disruption of mTORC1 signaling impacts iNKT-cell-mediated immune responses, including inflammatory conditions.
  • The findings highlight mTORC1 as a key regulator directing iNKT-cell lineage development and effector programs, potentially through transcription factor modulation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K